Usefulness of bucindolol in congestive heart failure
- 1 September 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (5) , 603-607
- https://doi.org/10.1016/0002-9149(90)90488-m
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placeboThe American Journal of Medicine, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of beta blockers on vascular resistance in systemic hypertensionThe American Journal of Cardiology, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Hemodynamic properties of bucindolol, a beta-adrenoreceptor blocking drug with vasodilator activityThe American Journal of Cardiology, 1986
- Six minute walking test for assessing exercise capacity in chronic heart failure.BMJ, 1986
- STUDIES ON THE VASODILATOR ACTIONS OF BUCINDOLOL IN THE RATClinical and Experimental Pharmacology and Physiology, 1986
- Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?Circulation, 1985
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975